< Back to previous page
Researcher
Corinne Vandermeulen
- Keywords (Ghent University):Vaccines
- Disciplines (Ghent University):Preventive medicine, Epidemiology, Other clinical sciences not elsewhere classified
- Disciplines (KU Leuven):Other chemical sciences, Microbiology, Systems biology, Laboratory medicine, Public health care, Public health sciences, Public health services, Social medical sciences, Nutrition and dietetics, Agricultural animal production, Food sciences and (bio)technology
- See also: Corinne Vandermeulen (Ghent University)
Affiliations
- Department of Diagnostic Sciences (Department)
Member
From1 Sep 2022 → Today - Environment and Health (Division)
Member
From1 Oct 2018 → 30 Sep 2021 - Clinical Pharmacology and Pharmacotherapy (Division)
Member
From1 Oct 2013 → 30 Sep 2018 - Laboratory of Clinical and Epidemiological Virology (Rega Institute) (Division)
Member
From1 Oct 1999 → 30 Sep 2001
Projects
1 - 10 of 12
- Prevalence and incidence of antibodies against SARS-CoV-2 in children measured for one year in Belgium: A sero-epidemiological prospective cohort studyFrom1 Sep 2021 → 31 Mar 2022Funding: Private funding of national origin - undefined
- Responding proactively to Covid-19 vaccination doubts to increase the effectiveness of vaccination campaigns in Belgium.From1 Nov 2020 → 31 Oct 2021Funding: FWO thematic call for applied research
- Pro-actively addressing the challenges for an effective uptake of COVID-19 vaccination in Belgium: a transdisciplinary approachFrom1 Nov 2020 → 31 Oct 2021Funding: FWO Special Call for Covid-19 research projects
- Prevalence and incidence of antibodies against SARS-CoV-2 in children measured for one year in Belgium.From1 Oct 2020 → 30 Jun 2021Funding: Private funding of national origin - undefined
- SPRAK36 projectFrom20 Aug 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- SARS-COV-2 Child study.From1 Aug 2020 → 30 Nov 2020Funding: Private funding of national origin - undefined
- Systems vaccinology in toddlers en childrenFrom1 Oct 2019 → 1 Oct 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Post-Truth and Vaccine Scepticism- A Husserlian PerspectiveFrom23 Sep 2019 → 23 Sep 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Put up a decision method for the vaccination policy in FlandersFrom1 Nov 2018 → 31 Jan 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
- Development of a Next-Generation, Dual-Target Rabies/Flavivirus Infectious DNA (iDNA) VaccineFrom1 Jan 2017 → 31 Dec 2021Funding: H2020-EU.3.2. - SOCIETAL CHALLENGES - Food security, sustainable agriculture, marine and maritime research and the bio-economy, H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and wellbeing
Publications
1 - 10 of 61
- Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial( )(2023)
Authors: Corinne Vandermeulen
Pages: 761 - 772 - A new fully liquid presentation of MenACWY-CRM conjugate vaccine: Results from a multicentre, randomised, controlled, observer-blind study(2021)
Authors: Corinne Vandermeulen
Pages: 6628 - 6636 - Influenza Vaccination in Patients With Congenital Heart Disease in the Pre-COVID-19 Era: Coverage Rate, Patient Characteristics, and Outcomes(2021)
Authors: Philip Moons, Steffen Fieuws, Corinne Vandermeulen, Fouke Ombelet, Eva Goossens, Liesbet Van Bulck, Werner Budts
Pages: 1472 - 1479 - Age-dependent seroprevalence of SARS-CoV-2 antibodies in school-aged children from areas with low and high community transmission(2021)
Authors: Lise Boey, Mathieu Roelants, Corinne Vandermeulen
Pages: 571 - 578 - Immunogenicity and Safety of the 9-Valent Human Papillomavirus Vaccine in Solid Organ Transplant Recipients and Adults Infected With Human Immunodeficiency Virus (HIV)(2021)
Authors: Lise Boey, Mathieu Roelants, Inge Derdelinckx, Eric Van Wijngaerden, Paul De Munter, Robin Vos, Dirk Kuypers, Johan Van Cleemput, Corinne Vandermeulen
Pages: E661 - E671 - Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27-45 years of age compared to women 16-26 years of age: An open-label phase 3 study(2021)
Authors: Corinne Vandermeulen
Pages: 2800 - 2809 - Seroprevalence of Antibodies against Diphtheria, Tetanus and Pertussis in Adult At-Risk Patients(2021)
Authors: Lise Boey, Mathieu Roelants, Kathleen Claes, Inge Derdelinckx, Wim Janssens, Chantal Mathieu, Johan Van Cleemput, Robin Vos, Corinne Vandermeulen
- A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate(2020)
Authors: Lorena Sanchez Felipe, Thomas Vercruysse, Sapna Sharma, Ji Ma, Viktor Lemmens, Robbert Boudewijns, Bert Malengier-Devlies, Laurens Liesenborghs, Suzanne Kaptein, Madina Rasulova, et al.
Pages: 320 - 325 - Value frameworks for vaccines: which dimensions are most relevant?(2020)
Authors: Jeroen Luyten, Roselinde Kessels, Corinne Vandermeulen
- Increased vaccine uptake and less perceived barriers toward vaccination in long-term care facilities that use multi-intervention manual for influenza campaigns(2020)
Authors: Lise Boey, Mathieu Roelants, Corinne Vandermeulen
Pages: 673 - 680